Regulatory News:
Arcam (STO:ARCM), listed on NASDAQ Stockholm, has received an EBM system order from an implant manufacturer in the US. The system will be used for production of orthopedic implants.
"We are happy to see a continued strong order intake from the orthopedic industry", says Magnus René, CEO of Arcam.
Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam's market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.
Arcam AB • Krokslätts Fabriker 27A SE-431 37 Mölndal, Sweden 46-31-710 32 00 www.arcam.com
This information was brought to you by Cision http://news.cision.com
Contacts:
Arcam AB
Magnus René, CEO
Tel: 0046 31 710 32 00
alt. cell: 0046 702 79 89 99
e-mail: magnus.rene@arcam.com
